Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kinjiro Co., Ltd. (4013:JPX), powered by AI.
Kinjiro Co., Ltd. is currently trading at ¥609. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Kinjiro Co., Ltd. on Alpha Lenz.
View Kinjiro Co., Ltd.'s valuation metrics on Alpha Lenz.
“Kinjiro Co., Ltd.'s ROE is 10.3%. Explore profitability and growth together.”
Ask for details →Kinjiro Co., Ltd. is a prominent player in Japan's healthcare and information technology sectors, offering specialized solutions to healthcare providers and institutions. The company primarily focuses on the development and provision of software systems that cater to the electronic medical records (EMR) and healthcare information management needs. By streamlining patient data management and improving healthcare workflow efficiency, Kinjiro aids medical professionals in delivering high-quality care. Beyond software development, the company engages in consulting services aimed at optimizing hospital management systems. Kinjiro Co., Ltd. is instrumental in advancing digital transformation within the healthcare industry in Japan, which is crucial given the country's aging population and the increasing demand for efficient medical services. It leverages cloud-based technologies to ensure that healthcare data is easily accessible, secure, and up-to-date, playing a significant role in the modernization of healthcare infrastructure.
“Kinjiro Co., Ltd.'s ROE is 10.3%. Explore profitability and growth together.”
Ask for details →Kinjiro Co., Ltd. (ticker: 4013) is a company listed on JPX in the Technology sector (Software - Application). It has approximately 308 employees.
The current price is 609 with a P/E ratio of -x and P/B of -x.
ROE is 10.33% and operating margin is 28.33%. Annual revenue is $5.4B.